Literature DB >> 15668502

Comparison of archival plasma and formalin-fixed paraffin-embedded tissue for genotyping in hepatocellular carcinoma.

Malin I L Sjöholm1, Gunilla Hoffmann, Stefan Lindgren, Joakim Dillner, Joyce Carlson.   

Abstract

Biobanks containing formalin-fixed paraffin-embedded tissue, as well as frozen serum or plasma, are important resources for molecular epidemiologic studies. However, few studies have compared the reliability of formalin-fixed tissue samples and archival plasma samples for genotyping. We determined the genotype of four proposed genetic risk factors for hepatocellular carcinoma [hereditary hemochromatosis (HFE 63 and 282), alpha(1)-antitrypsin deficiency (AAT 342) and cystic fibrosis (CFTR 508)] on formalin-fixed tissue samples, stored for up to 25 years, from 318 patients diagnosed with hepatocellular carcinoma and on plasma or serum samples from 31 of these patients. The genotypes were analyzed by RFLP or allele-specific amplification as well as by TaqMan assays. In addition, genotyping was attempted after whole genome amplification by multiple displacement amplification (MDA). Genotyping was successful in 94% of the tissue samples and successful and identical to the tissue samples from the same subjects in 98% of the plasma/serum samples. DNA from plasma samples could be amplified >5,000-fold by MDA and genotyping after MDA gave identical results to the genotyping of the same subjects before whole genome amplification. MDA amplification of the tissue samples was not successful. In summary, archival plasma was found to be an adequate source of efficiently amplifiable DNA. MDA on plasma samples allows analysis of multiple genotypes in epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15668502

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  10 in total

1.  COLD-PCR: improving the sensitivity of molecular diagnostics assays.

Authors:  Coren A Milbury; Jin Li; Pingfang Liu; G Mike Makrigiorgos
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

2.  Assessing the utility of whole-genome amplified serum DNA for array-based high throughput genotyping.

Authors:  Kristine L Bucasas; Gagan A Pandya; Sonal Pradhan; Robert D Fleischmann; Scott N Peterson; John W Belmont
Journal:  BMC Genet       Date:  2009-12-18       Impact factor: 2.797

3.  Performance of whole-genome amplified DNA isolated from serum and plasma on high-density single nucleotide polymorphism arrays.

Authors:  Daniel T Croft; Rick M Jordan; Heather L Patney; Craig D Shriver; Marina N Vernalis; Trevor J Orchard; Darrell L Ellsworth
Journal:  J Mol Diagn       Date:  2008-04-10       Impact factor: 5.568

4.  Ice-COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations.

Authors:  Coren A Milbury; Jin Li; G Mike Makrigiorgos
Journal:  Nucleic Acids Res       Date:  2010-10-11       Impact factor: 16.971

5.  Large fragment Bst DNA polymerase for whole genome amplification of DNA from formalin-fixed paraffin-embedded tissues.

Authors:  Sarit Aviel-Ronen; Chang Qi Zhu; Bradley P Coe; Ni Liu; Spencer K Watson; Wan L Lam; Ming Sound Tsao
Journal:  BMC Genomics       Date:  2006-12-12       Impact factor: 3.969

6.  Decreased serum cell-free DNA levels in rheumatoid arthritis.

Authors:  Marina Dunaeva; Bastiaan C Buddingh'; René E M Toes; Jolanda J Luime; Erik Lubberts; Ger J M Pruijn
Journal:  Auto Immun Highlights       Date:  2015-06-27

7.  CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment.

Authors:  K Beelen; M Opdam; T M Severson; R H T Koornstra; A D Vincent; M Hauptmann; R H N van Schaik; E M J J Berns; J B Vermorken; P J van Diest; S C Linn
Journal:  Breast Cancer Res Treat       Date:  2013-06-05       Impact factor: 4.872

8.  High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays.

Authors:  Yuker Wang; Victoria E H Carlton; George Karlin-Neumann; Ronald Sapolsky; Li Zhang; Martin Moorhead; Zhigang C Wang; Andrea L Richardson; Robert Warren; Axel Walther; Melissa Bondy; Aysegul Sahin; Ralf Krahe; Musaffe Tuna; Patricia A Thompson; Paul T Spellman; Joe W Gray; Gordon B Mills; Malek Faham
Journal:  BMC Med Genomics       Date:  2009-02-19       Impact factor: 3.063

9.  High-resolution melting analysis reveals genetic polymorphisms in microRNAs confer hepatocellular carcinoma risk in Chinese patients.

Authors:  Jia-Hui Qi; Jin Wang; Jinyun Chen; Fan Shen; Jing-Tao Huang; Subrata Sen; Xin Zhou; Song-Mei Liu
Journal:  BMC Cancer       Date:  2014-08-31       Impact factor: 4.430

10.  Cancer Registry follow-up for 17 million person-years of a nationwide maternity cohort.

Authors:  Matti Lehtinen; Heljä-Marja Surcel; Kari Natunen; Eero Pukkala; Joakim Dillner
Journal:  Cancer Med       Date:  2017-10-25       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.